Literature DB >> 19763724

Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head.

Deike Varoga1, Wolf Drescher, Melanie Pufe, Godo Groth, Thomas Pufe.   

Abstract

VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763724      PMCID: PMC2772917          DOI: 10.1007/s11999-009-1076-3

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  31 in total

1.  FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts.

Authors:  K Migita; H Tanaka; K Okamoto; N Yoshikawa; Y Ichinose; S Urayama; S Yamasaki; H Ida; Y Kawabe; A Kawakami; K Eguchi
Journal:  Lab Invest       Date:  2000-02       Impact factor: 5.662

2.  Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha.

Authors:  N Akeno; M F Czyzyk-Krzeska; T S Gross; T L Clemens
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

3.  Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells.

Authors:  P Martínez; P Esbrit; A Rodrigo; M V Alvarez-Arroyo; M E Martínez
Journal:  Osteoporos Int       Date:  2002-11       Impact factor: 4.507

4.  [Pathomorphological aspects and repair mechanisms of femur head necrosis].

Authors:  H Plenk; S Hofmann; M Breitenseher; M Urban
Journal:  Orthopade       Date:  2000-05       Impact factor: 1.087

5.  Effects of vascular endothelial growth factor on osteoclast induction during tooth movement in mice.

Authors:  M Kaku; S Kohno; T Kawata; I Fujita; C Tokimasa; K Tsutsui; K Tanne
Journal:  J Dent Res       Date:  2001-10       Impact factor: 6.116

6.  The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model.

Authors:  Thomas Pufe; Katharina E Scholz-Ahrens; Andreas T M Franke; Wolf Petersen; Rolf Mentlein; Deike Varoga; Bernhard Tillmann; Jürgen Schrezenmeir; Claus C Glüer
Journal:  Bone       Date:  2003-12       Impact factor: 4.398

7.  Effect of oligofructose or dietary calcium on repeated calcium and phosphorus balances, bone mineralization and trabecular structure in ovariectomized rats*.

Authors:  Katharina E Scholz-Ahrens; Yahya Açil; Jürgen Schrezenmeir
Journal:  Br J Nutr       Date:  2002-10       Impact factor: 3.718

8.  Osteonecrosis after renal transplantation in children.

Authors:  P J Stern; H G Watts
Journal:  J Bone Joint Surg Am       Date:  1979-09       Impact factor: 5.284

9.  Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.

Authors:  Thomas Pufe; Viola Harde; Wolf Petersen; Mary B Goldring; Bernhard Tillmann; Rolf Mentlein
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

10.  Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat.

Authors:  Thomas Pufe; Britt Wildemann; Wolf Petersen; Rolf Mentlein; Michael Raschke; Gerhard Schmidmaier
Journal:  Cell Tissue Res       Date:  2002-07-17       Impact factor: 5.249

View more
  17 in total

1.  Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents.

Authors:  Olivier Mir; Romain Coriat; Thomas Gregory; Stanislas Ropert; Bertrand Billemont; François Goldwasser
Journal:  Invest New Drugs       Date:  2010-02-24       Impact factor: 3.850

Review 2.  Intercellular cross-talk among bone cells: new factors and pathways.

Authors:  Natalie A Sims; Nicole C Walsh
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

3.  Association between vascular endothelial growth factor gene polymorphisms and the risk of osteonecrosis of the femoral head: Systematic review.

Authors:  Guo Ju Hong; Nuan Lin; Lei Lei Chen; Xiao Bo Chen; Wei He
Journal:  Biomed Rep       Date:  2015-10-06

4.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

5.  Bone turnover markers failed to predict the occurrence of osteonecrosis of the femoral head: a preliminary study.

Authors:  Thilo Floerkemeier; Stefanie Hirsch; Stefan Budde; Kerstin Radtke; Fritz Thorey; Henning Windhagen; Gabriela von Lewinski
Journal:  J Clin Lab Anal       Date:  2012-02       Impact factor: 2.352

6.  Histological characteristics of the human femoral head in patients with femoral neck fracture.

Authors:  Takashi Sakai; Daiki Iwana; Nobuo Nakamura; Takashi Nishii; Masaki Takao; Tetsu Watanabe; Hideki Yoshikawa; Nobuhiko Sugano
Journal:  Virchows Arch       Date:  2012-10-20       Impact factor: 4.064

7.  Total flavonoids of Rhizoma drynariae ameliorate steroid‑induced avascular necrosis of the femoral head via the PI3K/AKT pathway.

Authors:  Wenxue Lv; Mingxiu Yu; Qingyi Yang; Peng Kong; Bing Yan
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

8.  Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats.

Authors:  Sen Chen; Jianping Li; Hao Peng; Jianlin Zhou; Hongsong Fang
Journal:  Int J Mol Med       Date:  2014-02-05       Impact factor: 4.101

9.  The pathogenesis of nontraumatic osteonecrosis.

Authors:  Jesse Seamon; Thomas Keller; Jamal Saleh; Quanjun Cui
Journal:  Arthritis       Date:  2012-11-08

10.  Bone vascularization in normal and disease conditions.

Authors:  Christian Carulli; Massimo Innocenti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.